Moves are underway for a new national consensus group to set up and oversee uniform guidelines for the management of hepatitis in patients with cancer, including haematological malignancy. This follows the release of recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5), in relation to the screening, vaccination and treatment of patients with ...
Consensus group will address hepatitis in haematological malignancy
By Amanda Sheppeard
30 Apr 2016